Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (7,678,313)	$ (12,440,023)
Net cash used in operating activities:
Stock-based compensation	4,096,538	10,001,359
Gain on waiver of common stock issuable	(1,542,000)
Changes in operating assets and liabilities:
Research and development tax credit receivable	24,076	(485,349)
Other tax receivable	(39,843)	74,236
Joint development cost receivable	17,989	91,135
Prepaid expenses	(82,071)	27,095
Prepaid expenses - related party	(26,266)	158,504
Accounts payable and accrued liabilities	(151,232)	426,964
Accounts payable and accrued liabilities - related parties	19,557	87,085
Operating lease liability - related party	(23,091)
Net cash used in operating activities	(5,384,656)	(2,058,994)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from sale of common stock	12,209,021	900,000
Net cash provided by financing activities	12,209,021	900,000
Impact on cash from foreign currency translation	(15,044)	(25,513)
NET INCREASE (DECREASE) IN CASH	6,809,321	(1,184,507)
CASH AT BEGINNING OF YEAR	186,204	1,370,711
CASH AT END OF YEAR	6,995,525	186,204
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Cash paid for income taxes
Cash paid for interest expense
NONCASH INVESTING AND FINANCING ACTIVITIES:
Issuance of warrants to placement agents	247,452
Issuance of common stock issuable	$ 3,084,000